Skip to main content

The FDA Asks Bayer To Submit Problems Linked With Essure

The FDA Asks Bayer To Submit Problems Linked With Essure

The FDA Asks Bayer To Submit Problems Linked With Essure

Introduction

Last week, the U.S. Food and Drug Administration (FDA) issued a letter to Bayer indicating requirements for submitting adverse event reports and postmarket activities associated with Essure, a permanent birth control device sold in the U.S. until 2018.

According to the letter issued, Bayer gets a variance, considering the anticipated volume and nature of the information, which gives the company a year to submit postmarket adverse event reports. The variance was requested by the manufacturer as it was receiving information about problems with the recalled Essure birth control device through social media and other adverse event reports.

The variance is valid for one year unless the FDA extends it, after which the manufacturer will be required to follow the regular adverse event reporting requirements for all Essure-associated reportable events.

The reports received by the manufacturer will be made publicly available by the FDA at pre-specified time points over the next year, starting in July 2020.

Nearly 18,000 lawsuits have been filed against Bayer, each involving similar allegations that the permanent birth control device resulted in painful and debilitating complications.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.